244 related articles for article (PubMed ID: 21673857)
41. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
[TBL] [Abstract][Full Text] [Related]
42. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
[TBL] [Abstract][Full Text] [Related]
43. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?
Cameron A; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
Value Health; 2012; 15(5):664-73. PubMed ID: 22867775
[TBL] [Abstract][Full Text] [Related]
44. Availability, affordability and costs of pediatric medicines in Mongolia.
Dorj G; Sunderland B; Sanjjav T; Dorj G; Gendenragchaa B
BMC Pediatr; 2018 May; 18(1):149. PubMed ID: 29720129
[TBL] [Abstract][Full Text] [Related]
45. Regional trends in the use of short-acting and long-acting contraception accessed through the private and public sectors.
Ugaz JI; Chatterji M; Gribble JN; Mitchell S
Int J Gynaecol Obstet; 2015 Aug; 130 Suppl 3():E3-7. PubMed ID: 26001703
[TBL] [Abstract][Full Text] [Related]
46. Availability of medicines in public sector health facilities of two North Indian States.
Prinja S; Bahuguna P; Tripathy JP; Kumar R
BMC Pharmacol Toxicol; 2015 Dec; 16():43. PubMed ID: 26699711
[TBL] [Abstract][Full Text] [Related]
47. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
[TBL] [Abstract][Full Text] [Related]
48. What essential medicines for children are on the shelf?
Robertson J; Forte G; Trapsida JM; Hill S
Bull World Health Organ; 2009 Mar; 87(3):231-7. PubMed ID: 19377720
[TBL] [Abstract][Full Text] [Related]
49. Medicines availability for non-communicable diseases: the case for standardized monitoring.
Robertson J; Macé C; Forte G; de Joncheere K; Beran D
Global Health; 2015 May; 11():18. PubMed ID: 25947094
[TBL] [Abstract][Full Text] [Related]
50. Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania's Health System.
Embrey M; Vialle-Valentin C; Dillip A; Kihiyo B; Mbwasi R; Semali IA; Chalker JC; Liana J; Lieber R; Johnson K; Rutta E; Kimatta S; Shekalaghe E; Valimba R; Ross-Degnan D
PLoS One; 2016; 11(11):e0164332. PubMed ID: 27824876
[TBL] [Abstract][Full Text] [Related]
51. Why do some physicians in Portuguese-speaking African countries work exclusively for the private sector? Findings from a mixed-methods study.
Russo G; de Sousa B; Sidat M; Ferrinho P; Dussault G
Hum Resour Health; 2014 Sep; 12():51. PubMed ID: 25209103
[TBL] [Abstract][Full Text] [Related]
52. Availability and affordability of children essential medicines in health facilities of southern nations, nationalities, and people region, Ethiopia: key determinants for access.
Tadesse T; Abuye H; Tilahun G
BMC Public Health; 2021 Apr; 21(1):714. PubMed ID: 33849513
[TBL] [Abstract][Full Text] [Related]
53. Investigating the Effect of Syrian Refugees on the Pharmaceutical Sector in Jordan.
Daher A; Alabbadi I
Arch Iran Med; 2017 Aug; 20(8):538-546. PubMed ID: 28846018
[TBL] [Abstract][Full Text] [Related]
54. Health seeking behaviours and private sector delivery of care for non-communicable diseases in low- and middle-income countries: a systematic review.
Brindley C; Wijemunige N; Dieteren C; Bom J; Meessen B; Bonfrer I
BMC Health Serv Res; 2024 Jan; 24(1):127. PubMed ID: 38263128
[TBL] [Abstract][Full Text] [Related]
55. Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya.
Ooms GI; van Oirschot J; Okemo D; Waldmann B; Erulu E; Mantel-Teeuwisse AK; van den Ham HA; Reed T
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009702. PubMed ID: 34398889
[TBL] [Abstract][Full Text] [Related]
56. Availability and price of malaria rapid diagnostic tests in the public and private health sectors in 2011: results from 10 nationally representative cross-sectional retail surveys.
Poyer S; Shewchuk T; Tougher S; Ye Y; ; Mann AG; Willey BA; Thomson R; Amuasi JH; Ren R; Wamukoya M; Taylor M; Nguah SB; Mberu B; Kalolella A; Juma E; Festo C; Johanes B; Diap G; Bruxvoort K; Ansong D; Hanson K; Arnold F; Goodman C
Trop Med Int Health; 2015 Jun; 20(6):744-56. PubMed ID: 25728761
[TBL] [Abstract][Full Text] [Related]
57. Are essential medicines in Malaysia accessible, affordable and available?
Saleh K; Ibrahim MI
Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951
[TBL] [Abstract][Full Text] [Related]
58. The prices people pay for medicines in Zimbabwe.
Gavaza P; Simoyi T; Makunike B; Maponga CC
Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842
[TBL] [Abstract][Full Text] [Related]
59. Availability, affordability, and prescribing pattern of medicines in Sudan.
Cheraghali AM; Idries AM
Pharm World Sci; 2009 Apr; 31(2):209-15. PubMed ID: 19263235
[TBL] [Abstract][Full Text] [Related]
60. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
